AI automation and clinical trial operations software for life sciences
Mushroom Solutions builds automation and clinical trial operations software for life sciences, with active work on FDA 21 CFR Part 11 and GDPR compliance features. Its stack centers on Azure data services, and it is adopting Microsoft Fabric, Databricks, Delta Lake and Synapse, which points to a lakehouse-style data platform build. Hiring has slowed and is split across data, sales, engineering and product roles in India and the United States.
Mushroom Solutions is a privately held company founded in 2019 and headquartered in Edison, New Jersey, with 51–200 employees. It sells automation software and services to life sciences organizations, including trial sponsors, CROs and research sites. Its CTOps platform covers clinical trial operations such as study design, participant engagement, decentralized trials and regulatory compliance. The company also offers bot-based process automation, AI document processing, regulatory tooling, and automation for supply chain and finance workflows. It hires in India and the United States.
Mushroom Solutions runs mainly on Azure, including Data Factory, Synapse Analytics, Data Lake Storage and SQL Database. It also uses Databricks, Power BI, Python, Django, React, PostgreSQL, Docker and Kubernetes.
According to its job posts, Mushroom Solutions is building an application for FDA 21 CFR Part 11 compliance and adding GDPR compliance features, while scaling its data pipelines.
Mushroom Solutions is headquartered in Edison, New Jersey, United States. It has 51–200 employees and hires in the United States and India.
Other companies in the same industry, closest in size
Mushroom Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.